ID PTK7_DROME Reviewed; 1033 AA. AC Q6AWJ9; C4IXZ4; Q24327; DT 03-NOV-2009, integrated into UniProtKB/Swiss-Prot. DT 03-OCT-2006, sequence version 1. DT 02-SEP-2026, entry version 153. DE RecName: Full=Tyrosine-protein kinase-like otk {ECO:0000303|PubMed:11604138, ECO:0000303|PubMed:1371458, ECO:0000303|PubMed:15456725}; DE AltName: Full=Gp160-Dtrk {ECO:0000312|EMBL:CAA45053.1}; DE Short=Dtrk {ECO:0000312|EMBL:CAA45053.1}; DE AltName: Full=Off-track {ECO:0000312|EMBL:AAF58596.1}; DE AltName: Full=Tyrosine-protein kinase-like 7 homolog; DE Flags: Precursor; GN Name=otk {ECO:0000312|EMBL:AAT94478.1, GN ECO:0000312|FlyBase:FBgn0004839}; ORFNames=CG8967; OS Drosophila melanogaster (Fruit fly). OC Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Altocrustacea; Allotriocarida; OC Hexapoda; Insecta; Pterygota; Neoptera; Eumetabola; Endopterygota; OC Aparaglossata; Panorpida; Diptera; Brachycera; Muscomorpha; Ephydroidea; OC Drosophilidae; Drosophila; Sophophora. OX NCBI_TaxID=7227; RN [1] {ECO:0000305, ECO:0000312|EMBL:CAA45053.1} RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE RP SPECIFICITY, AND DEVELOPMENTAL STAGE. RC STRAIN=Canton-S {ECO:0000312|EMBL:CAA45053.1}; RC TISSUE=Embryo {ECO:0000269|PubMed:1371458}; RX PubMed=1371458; DOI=10.1002/j.1460-2075.1992.tb05067.x; RA Pulido D., Campuzano S., Koda T., Modolell J., Barbacid M.; RT "Dtrk, a Drosophila gene related to the trk family of neurotrophin RT receptors, encodes a novel class of neural cell adhesion molecule."; RL EMBO J. 11:391-404(1992). RN [2] {ECO:0000312|EMBL:AAF58596.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Berkeley; RX PubMed=10731132; DOI=10.1126/science.287.5461.2185; RA Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D., RA Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F., RA George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N., RA Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C., RA Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C., RA Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A., RA An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A., RA Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V., RA Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J., RA Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E., RA Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B., RA Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., RA Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., RA Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., RA Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., RA Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M., RA Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D., RA Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F., RA Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D., RA Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A., RA Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C., RA McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C., RA Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L., RA Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., RA Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., RA Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F., RA Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J., RA Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R., RA Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y., RA Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T., RA Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S., RA Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W., RA Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., RA Venter J.C.; RT "The genome sequence of Drosophila melanogaster."; RL Science 287:2185-2195(2000). RN [3] {ECO:0000305, ECO:0000312|EMBL:AAF58596.1} RP GENOME REANNOTATION. RC STRAIN=Berkeley; RX PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083; RA Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S., RA Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E., RA Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P., RA Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A., RA Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M., RA Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.; RT "Annotation of the Drosophila melanogaster euchromatic genome: a systematic RT review."; RL Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002). RN [4] {ECO:0000312|EMBL:AAT94478.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Berkeley {ECO:0000312|EMBL:AAT94478.1}; RC TISSUE=Larva, and Pupae; RA Stapleton M., Carlson J.W., Booth B., Chavez C., Frise E., George R.A., RA Pacleb J.M., Park S., Wan K.H., Yu C., Rubin G.M., Celniker S.E.; RL Submitted (MAY-2009) to the EMBL/GenBank/DDBJ databases. RN [5] {ECO:0000305} RP FUNCTION, INTERACTION WITH PLEXA, AND DISRUPTION PHENOTYPE. RX PubMed=11604138; DOI=10.1016/s0896-6273(01)00446-9; RA Winberg M.L., Tamagnone L., Bai J., Comoglio P.M., Montell D., RA Goodman C.S.; RT "The transmembrane protein Off-track associates with Plexins and functions RT downstream of Semaphorin signaling during axon guidance."; RL Neuron 32:53-62(2001). RN [6] {ECO:0000305} RP FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE. RX PubMed=15456725; DOI=10.1242/dev.01406; RA Cafferty P., Yu L., Rao Y.; RT "The receptor tyrosine kinase Off-track is required for layer-specific RT neuronal connectivity in Drosophila."; RL Development 131:5287-5295(2004). RN [7] {ECO:0000305} RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-678, AND IDENTIFICATION BY RP MASS SPECTROMETRY. RC TISSUE=Embryo {ECO:0000269|PubMed:18327897}; RX PubMed=18327897; DOI=10.1021/pr700696a; RA Zhai B., Villen J., Beausoleil S.A., Mintseris J., Gygi S.P.; RT "Phosphoproteome analysis of Drosophila melanogaster embryos."; RL J. Proteome Res. 7:1675-1682(2008). RN [8] {ECO:0000305} RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-524, AND IDENTIFICATION BY MASS RP SPECTROMETRY. RX PubMed=19349973; DOI=10.1038/nbt.1532; RA Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., RA Schiess R., Aebersold R., Watts J.D.; RT "Mass-spectrometric identification and relative quantification of N-linked RT cell surface glycoproteins."; RL Nat. Biotechnol. 27:378-386(2009). CC -!- FUNCTION: Acts as a calcium-dependent, homophilic cell adhesion CC molecule that regulates neural recognition during the development of CC the nervous system. Component of the repulsive Plexin signaling CC response to regulate motor axon guidance at the embryonic stage. Also CC component of a receptor complex that is required in the adult visual CC system to innervate the lamina layer; specific targeting of R1-R6 CC axons. {ECO:0000269|PubMed:11604138, ECO:0000269|PubMed:1371458, CC ECO:0000269|PubMed:15456725}. CC -!- SUBUNIT: Interacts with plexA; component of a receptor complex that CC mediates the repulsive signaling in response to Semaphorin ligands. CC {ECO:0000269|PubMed:11604138}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1371458}; CC Single-pass type I membrane protein {ECO:0000269|PubMed:1371458}. CC -!- TISSUE SPECIFICITY: Dynamically expressed during embryogenesis in CC several areas of the developing nervous system, including neurons and CC fasciculating axons. Expression in stage 7 embryos is seen in the CC anterior midgut primordia, cephalic furrow and along the germinal band. CC At stage 11, expression is in 15 stripes over the trunk region, and in CC the anterior and posterior midgut primordia. Stage 12 shows expression CC in the developing nervous system, procephalic lobe and maxillar bud. CC Stage 13 shows expression in the ventral cord, maxillar segment and in CC three regions of the gut. At stage 16 expression is preferentially CC detected throughout the nervous system, including the neuromers in the CC ventral cord and the supraesophageal ganglion (at protein level). In CC larva, expression is seen in developing R cells and is localized CC predominantly to R1-R6 growth cones. {ECO:0000269|PubMed:1371458, CC ECO:0000269|PubMed:15456725}. CC -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically, during CC early to mid embryogenesis and early pupation. CC {ECO:0000269|PubMed:1371458}. CC -!- DISRUPTION PHENOTYPE: Axon guidance defects. R-cell differentiation and CC cell fate determination are normal, but many R1-R6 axons connect CC abnormally to medulla instead of innervating lamina. CC {ECO:0000269|PubMed:11604138, ECO:0000269|PubMed:15456725}. CC -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein CC kinase family. Insulin receptor subfamily. {ECO:0000255|PROSITE- CC ProRule:PRU00159}. CC -!- CAUTION: This protein has been proposed to undergo autophosphorylation CC on tyrosine residues which is induced in response to cell adhesion CC (PubMed:1371458). However, as mammalian orthologs of this protein seem CC to lack kinase activity this protein may associate with, and be CC phosphorylated by, an unknown active tyrosine kinase. CC {ECO:0000305|PubMed:1371458}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X63453; CAA45053.1; -; mRNA. DR EMBL; AE013599; AAF58596.1; -; Genomic_DNA. DR EMBL; BT015249; AAT94478.1; -; mRNA. DR EMBL; BT083425; ACQ91629.1; -; mRNA. DR PIR; S19247; S19247. DR RefSeq; NP_523705.2; NM_078981.3. DR PDB; 6S9F; X-ray; 1.97 A; A/B=24-580. DR AlphaFoldDB; Q6AWJ9; -. DR SMR; Q6AWJ9; -. DR BioGRID; 62067; 10. DR FunCoup; Q6AWJ9; 259. DR IntAct; Q6AWJ9; 5. DR MINT; Q6AWJ9; -. DR STRING; 7227.FBpp0087135; -. DR GlyCosmos; Q6AWJ9; 8 sites, No reported glycans. DR GlyGen; Q6AWJ9; 8 sites. DR iPTMnet; Q6AWJ9; -. DR PaxDb; 7227-FBpp0087135; -. DR PeptideAtlas; Q6AWJ9; -. DR DNASU; 36283; -. DR EnsemblMetazoa; FBtr0088028; FBpp0087135; FBgn0004839. DR GeneID; 36283; -. DR KEGG; dme:Dmel_CG8967; -. DR UCSC; CG8967-RA; d. melanogaster. DR AGR; FB:FBgn0004839; -. DR CTD; 36283; -. DR FlyBase; FBgn0004839; otk. DR VEuPathDB; VectorBase:FBgn0004839; -. DR eggNOG; KOG1026; Eukaryota. DR eggNOG; KOG4475; Eukaryota. DR HOGENOM; CLU_012268_0_0_1; -. DR InParanoid; Q6AWJ9; -. DR OMA; SHLHIEA; -. DR OrthoDB; 2413561at2759; -. DR PhylomeDB; Q6AWJ9; -. DR Reactome; R-DME-1474228; Degradation of the extracellular matrix. DR Reactome; R-DME-210991; Basigin interactions. DR Reactome; R-DME-216083; Integrin cell surface interactions. DR Reactome; R-DME-428542; Regulation of commissural axon pathfinding by SLIT and ROBO. DR Reactome; R-DME-433692; Proton-coupled monocarboxylate transport. DR Reactome; R-DME-9749641; Aspirin ADME. DR SignaLink; Q6AWJ9; -. DR BioGRID-ORCS; 36283; 0 hits in 3 CRISPR screens. DR GenomeRNAi; 36283; -. DR PRO; PR:Q6AWJ9; -. DR Proteomes; UP000000803; Chromosome 2R. DR Bgee; FBgn0004839; Expressed in escort cell (Drosophila) in ovary and 61 other cell types or tissues. DR ExpressionAtlas; Q6AWJ9; baseline and differential. DR GO; GO:0030424; C:axon; IDA:FlyBase. DR GO; GO:0016020; C:membrane; ISM:FlyBase. DR GO; GO:0005886; C:plasma membrane; IDA:FlyBase. DR GO; GO:0005524; F:ATP binding; IEA:InterPro. DR GO; GO:0050839; F:cell adhesion molecule binding; IDA:FlyBase. DR GO; GO:0098632; F:cell-cell adhesion mediator activity; IBA:GO_Central. DR GO; GO:0046982; F:protein heterodimerization activity; IPI:FlyBase. DR GO; GO:0042803; F:protein homodimerization activity; IPI:FlyBase. DR GO; GO:0030215; F:semaphorin receptor binding; TAS:FlyBase. DR GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:FlyBase. DR GO; GO:0004888; F:transmembrane signaling receptor activity; IGI:FlyBase. DR GO; GO:0017147; F:Wnt-protein binding; IPI:FlyBase. DR GO; GO:0007411; P:axon guidance; IMP:FlyBase. DR GO; GO:0007155; P:cell adhesion; IDA:FlyBase. DR GO; GO:0070593; P:dendrite self-avoidance; IBA:GO_Central. DR GO; GO:0007156; P:homophilic cell-cell adhesion; IBA:GO_Central. DR GO; GO:0048804; P:imaginal disc-derived female genitalia morphogenesis; IGI:FlyBase. DR GO; GO:0048803; P:imaginal disc-derived male genitalia morphogenesis; IGI:FlyBase. DR GO; GO:0035260; P:internal genitalia morphogenesis; IGI:FlyBase. DR GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:FlyBase. DR GO; GO:0072499; P:photoreceptor cell axon guidance; IMP:FlyBase. DR GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; IBA:GO_Central. DR GO; GO:0031290; P:retinal ganglion cell axon guidance; IMP:UniProtKB. DR CDD; cd00096; Ig; 2. DR CDD; cd05046; PTK_CCK4; 1. DR FunFam; 1.10.510.10:FF:000954; Tyrosine-protein kinase-like otk; 1. DR FunFam; 2.60.40.10:FF:001805; Tyrosine-protein kinase-like otk; 1. DR FunFam; 2.60.40.10:FF:002027; Tyrosine-protein kinase-like otk; 1. DR FunFam; 2.60.40.10:FF:002086; Tyrosine-protein kinase-like otk; 1. DR FunFam; 2.60.40.10:FF:002809; Tyrosine-protein kinase-like otk; 1. DR FunFam; 3.30.200.20:FF:001776; Tyrosine-protein kinase-like otk; 1. DR FunFam; 2.60.40.10:FF:002127; tyrosine-protein kinase-like otk; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 5. DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR013098; Ig_I-set. DR InterPro; IPR003599; Ig_sub. DR InterPro; IPR003598; Ig_sub2. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR050122; RTK. DR InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom. DR InterPro; IPR008266; Tyr_kinase_AS. DR InterPro; IPR020635; Tyr_kinase_cat_dom. DR PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1. DR PANTHER; PTHR24416:SF349; TYROSINE-PROTEIN KINASE RYK; 1. DR Pfam; PF07679; I-set; 3. DR Pfam; PF13927; Ig_3; 1. DR Pfam; PF07714; PK_Tyr_Ser-Thr; 1. DR PRINTS; PR00109; TYRKINASE. DR SMART; SM00409; IG; 5. DR SMART; SM00408; IGc2; 5. DR SMART; SM00219; TyrKc; 1. DR SUPFAM; SSF48726; Immunoglobulin; 4. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS50835; IG_LIKE; 5. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. DR PROSITE; PS00109; PROTEIN_KINASE_TYR; 1. DR PDBsum; 6S9F; -. PE 1: Evidence at protein level; KW 3D-structure; Cell adhesion; Cell membrane; Disulfide bond; Glycoprotein; KW Immunoglobulin domain; Membrane; Neurogenesis; Phosphoprotein; Receptor; KW Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix. FT SIGNAL 1..22 FT /evidence="ECO:0000255" FT CHAIN 23..1033 FT /note="Tyrosine-protein kinase-like otk" FT /evidence="ECO:0000255" FT /id="PRO_5000145927" FT TOPO_DOM 23..581 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 582..602 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 603..1033 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 25..114 FT /note="Ig-like C2-type 1" FT /evidence="ECO:0000255" FT DOMAIN 113..199 FT /note="Ig-like C2-type 2" FT /evidence="ECO:0000255" FT DOMAIN 251..365 FT /note="Ig-like C2-type 3" FT /evidence="ECO:0000255" FT DOMAIN 368..463 FT /note="Ig-like C2-type 4" FT /evidence="ECO:0000255" FT DOMAIN 468..558 FT /note="Ig-like C2-type 5" FT /evidence="ECO:0000255" FT DOMAIN 692..1028 FT /note="Protein kinase; inactive" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159, FT ECO:0000305" FT REGION 617..679 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 718..760 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 655..673 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 720..731 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 678 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:18327897" FT CARBOHYD 39 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 336 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 417 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 429 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 444 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 457 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 512 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 524 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:19349973" FT DISULFID 46..95 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 137..188 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 276..354 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 399..447 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT DISULFID 490..542 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT CONFLICT 221 FT /note="E -> Q (in Ref. 1; CAA45053)" FT /evidence="ECO:0000305" FT CONFLICT 239 FT /note="G -> S (in Ref. 4; ACQ91629)" FT /evidence="ECO:0000305" FT CONFLICT 271 FT /note="P -> H (in Ref. 1; CAA45053)" FT /evidence="ECO:0000305" FT CONFLICT 311 FT /note="I -> F (in Ref. 1; CAA45053)" FT /evidence="ECO:0000305" FT CONFLICT 402 FT /note="Q -> L (in Ref. 4; ACQ91629)" FT /evidence="ECO:0000305" FT CONFLICT 629 FT /note="V -> I (in Ref. 1; CAA45053)" FT /evidence="ECO:0000305" FT CONFLICT 772 FT /note="D -> E (in Ref. 1; CAA45053)" FT /evidence="ECO:0000305" FT HELIX 247..251 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 255..258 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 262..267 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 272..274 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 277..279 FT /evidence="ECO:0007829|PDB:6S9F" FT HELIX 282..284 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 289..295 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 298..304 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 329..332 FT /evidence="ECO:0007829|PDB:6S9F" FT TURN 334..336 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 339..343 FT /evidence="ECO:0007829|PDB:6S9F" FT HELIX 346..348 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 350..358 FT /evidence="ECO:0007829|PDB:6S9F" FT HELIX 366..368 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 369..374 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 378..381 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 386..389 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 393..397 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 408..413 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 424..426 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 432..436 FT /evidence="ECO:0007829|PDB:6S9F" FT HELIX 439..441 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 443..451 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 454..472 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 478..481 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 486..488 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 491..496 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 499..504 FT /evidence="ECO:0007829|PDB:6S9F" FT TURN 511..513 FT /evidence="ECO:0007829|PDB:6S9F" FT TURN 516..518 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 519..521 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 527..529 FT /evidence="ECO:0007829|PDB:6S9F" FT HELIX 534..536 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 538..545 FT /evidence="ECO:0007829|PDB:6S9F" FT STRAND 550..560 FT /evidence="ECO:0007829|PDB:6S9F" SQ SEQUENCE 1033 AA; 114267 MW; 559659540BDE66F5 CRC64; MTARMISICG LVMALMMASV LASSSRFQRV PQSQSVVENE SVKFECESTD SYSELHYDWL HNGHRIAYDK RVHQIGSNLH IEAVRRTEDV GNYVCIATNL ASGAREASPP AKLSVIYLES ASVQLLGSNR NELLLKCHVE GASGDLEPLE IEWYRNSEKL STWKNVQLDQ HRLIIRQPGS EDDGLYRCTA SNAAGRVMSK QGYVYQSSVK CLPRLPRRKN EKMMESWDKQ TFLCRGKRGG AAGLEALPAA PEDLRIVQGP IGQSIIKEGE PTALTCLYEL PDELKNQRIQ LRWRKDGKLL RQVELGGSAP IPGHSFDSGK DALLREDARL VLHKQNGTLS FASIIASDAG QYQCQLQLEA HAPINSSPGI LEVIEQLKFV PQPTSKNLEL DAVVAKVHCK AQGTPTPQVQ WVRDGENTTL PDHVEVDANG TLIFRNVNSE HRGNYTCLAT NSQGQINATV AINVVVTPKF SVPPVGPIET SEQGTVVMHC QAIGDPKPTI QWDKDLKYLS ENNTDRERFR FLENGTLEIR NVQVEDEGSY GCTIGNSAGL KREDVQLVVK TTGDGFAPEE SGGDGFLVTR AVLITMTVAL AYIVLVVGLM LWCRYRRQAR KARLNDLSTK EAGGDQPDVA GNGKGSEQEP CLSKQHNGHS KSRSKSSGDA QKSDDTACSQ QSRASKKSAH IYEQLALPRS GLSELIQIGR GEFGDVFVGK LKATLVTSPS DKDADTEKQH SNSENGSGGS GSGSTTLSTL NEKRRSKTSM DDIEEIKEEE QDQHNQSGLE QLVLVKALNK VKDEQACQEF RRQLDLLRAI SHKGVVRLFG LCREKDPHYM VLEYTDWGDL KQFLLATAGK VNTATAGSSS PPPLTTSQVL AVAYQIARGM DAIYRARFTH RDLATRNCVI SSEFIVKVSY PALCKDKYSR EYHKHRNTLL PIRWLAPECI QEDEYTTKSD IFAYGVVVWE LFNQATKLPH EELTNEQVVQ RSQAGSLEWS VAEATPDSLR EILLSCWVSN PKERPSFSQL GAALSKAMQS AEK //